These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2172943)

  • 1. The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK.
    Cauvin A; Buscail L; Gourlet P; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J
    Peptides; 1990; 11(4):773-7. PubMed ID: 2172943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.
    Vandermeers A; Vandenborre S; Hou X; de Neef P; Robberecht P; Vandermeers-Piret MC; Christophe J
    Eur J Biochem; 1992 Sep; 208(3):815-9. PubMed ID: 1327769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist.
    Robberecht P; Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers-Piret MC; Vandermeers A; Christophe J
    Eur J Biochem; 1992 Jul; 207(1):239-46. PubMed ID: 1321043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.
    Buscail L; Gourlet P; Cauvin A; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J
    FEBS Lett; 1990 Mar; 262(1):77-81. PubMed ID: 2156735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
    Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
    Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord.
    Cauvin A; Robberecht P; De Neef P; Gourlet P; Vandermeers A; Vandermeers-Piret MC; Christophe J
    Regul Pept; 1991 Aug; 35(2):161-73. PubMed ID: 1661904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.
    Gourlet P; Woussen-Colle MC; Robberecht P; de Neef P; Cauvin A; Vandermeers-Piret MC; Vandermeers A; Christophe J
    Eur J Biochem; 1991 Jan; 195(2):535-41. PubMed ID: 1997328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
    Robberecht P; Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers-Piret MC; Vandermeers A; Christophe J
    Mol Pharmacol; 1992 Aug; 42(2):347-55. PubMed ID: 1325033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
    Suda K; Smith DM; Ghatei MA; Murphy JK; Bloom SR
    J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells.
    Moody TW; Zia F; Makheja A
    Peptides; 1993; 14(2):241-6. PubMed ID: 8387187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of pituitary adenylate cyclase-activating polypeptide receptors in Y-79 human retinoblastoma cells.
    Olianas MC; Ennas MG; Lampis G; Onali P
    J Neurochem; 1996 Sep; 67(3):1293-300. PubMed ID: 8752138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
    Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
    Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the interaction of VIP binding sites with VIP and PACAP in human brain.
    Suda K; Smith DM; Ghatei MA; Bloom SR
    Neurosci Lett; 1992 Mar; 137(1):19-23. PubMed ID: 1320752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of ovine pituitary adenylate cyclase-activating peptide (PACAP-38) with rat lung membranes.
    Bitar KG; Coy DH
    Peptides; 1993; 14(3):621-7. PubMed ID: 8392724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
    Guijarro LG; Rodriguez-Henche N; García-López E; Noguerales F; Dapena MA; Juarranz MG; Prieto JC
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas.
    Vertongen P; Devalck C; Sariban E; De Laet MH; Martelli H; Paraf F; Hélardot P; Robberecht P
    J Cell Physiol; 1996 Apr; 167(1):36-46. PubMed ID: 8698838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.